Reasons for Intent to Discontinue and Remove Long-Acting Reversible Contraceptives: National Survey of Family Growth 2017-2019
- PMID: 35005999
- DOI: 10.1089/jwh.2021.0272
Reasons for Intent to Discontinue and Remove Long-Acting Reversible Contraceptives: National Survey of Family Growth 2017-2019
Abstract
Background: Long-acting reversible contraceptives (LARCs) are highly effective forms of contraception, which can reduce the risk of unintended pregnancy. Despite LARC effectiveness, women may desire to discontinue this method. This study will examine reasons for intent to discontinue and remove LARCs among U.S. women 15-49 years of age from 2017 to 2019. Methods: The National Survey of Family Growth 2017-2019 was utilized with a sample of 6141 female respondents. Descriptive statistics for intention to discontinue LARCs, difficulty removing LARCs, and reasons for LARC discontinuation and removal were examined. Rao-Scott chi-square tests were conducted in SAS. Results: Overall, 22.9% of women reported ever using LARCs. Among LARC users, most women (81.2%) reported using LARC in the past 10 years. Among these women, 63.9% intended to discontinue LARCs, and 11.5% had difficulty removing LARCs. Reasons for wanting to discontinue LARCs include side effects (29.6%), LARC expiration (26.8%), LARC complications (19.3%), and decided to get pregnant (15.9%). Primary reasons reported for difficulty removing LARCs included: complications (68.3%), other reasons (13.4%), discouragement by provider (5.8%), and provider's inability to remove (4.9%). Conclusions: Given that women who use a LARC method rely on providers to remove this contraceptive method, understanding the reasons for discontinuation and difficulties encountered is needed. Findings from this nationally representative sample identified provider-level and system-level barriers for LARC removal. To respect the reproductive autonomy of LARC users' method for pregnancy prevention, these barriers must be overcome.
Keywords: LARC; LARC discontinuation; LARC removal; LARC removal difficulty; LARC removal intention; reproductive autonomy.
Similar articles
-
Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.Reprod Health. 2022 Feb 19;19(1):47. doi: 10.1186/s12978-022-01357-2. Reprod Health. 2022. PMID: 35183214 Free PMC article.
-
Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.Reprod Health. 2018 May 24;15(1):85. doi: 10.1186/s12978-018-0543-2. Reprod Health. 2018. PMID: 29793501 Free PMC article.
-
Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.Reprod Health. 2016 Aug 22;13(1):96. doi: 10.1186/s12978-016-0211-3. Reprod Health. 2016. PMID: 27549429 Free PMC article.
-
Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.BMJ Sex Reprod Health. 2023 Oct;49(4):282-292. doi: 10.1136/bmjsrh-2022-201560. Epub 2023 Feb 21. BMJ Sex Reprod Health. 2023. PMID: 36810206 Review.
-
Multilevel Barriers to Long-Acting Reversible Contraceptive Uptake: A Narrative Review.Health Promot Pract. 2024 Jul;25(4):717-725. doi: 10.1177/15248399231211531. Epub 2023 Nov 18. Health Promot Pract. 2024. PMID: 37978809 Review.
Cited by
-
Social Determinants of Health and Patient-Reported Difficult Discontinuation of Long-Acting Reversible Contraception.J Womens Health (Larchmt). 2024 Dec;33(12):1635-1644. doi: 10.1089/jwh.2023.0857. Epub 2024 Jul 22. J Womens Health (Larchmt). 2024. PMID: 39034886
-
"I felt my rights were violated": Challenges with the discontinuation of provider-dependent contraceptive methods in Eastern Uganda.Contracept Reprod Med. 2025 Mar 18;10(1):21. doi: 10.1186/s40834-025-00354-7. Contracept Reprod Med. 2025. PMID: 40102954 Free PMC article.
-
Trends in Continuation of Long-Acting Reversible Contraception Among Adolescents Receiving Medicaid.J Adolesc Health. 2024 Sep;75(3):487-495. doi: 10.1016/j.jadohealth.2024.04.029. Epub 2024 Jul 9. J Adolesc Health. 2024. PMID: 38980246
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous